These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2565383)

  • 1. Characterization of the solution degradation products of etintidine, an H2-receptor antagonist.
    Oyler AR; Naldi RE; Stefanick SM; Lloyd JR; Graden DA; Cotter ML
    J Pharm Sci; 1989 Jan; 78(1):21-4. PubMed ID: 2565383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-pressure liquid chromatographic analysis of cimetidine, a histamine H2-receptor antagonist, in blood and urine.
    Randolph WC; Osborne VL; Walkenstein SS; Intoccia AP
    J Pharm Sci; 1977 Aug; 66(8):1148-50. PubMed ID: 19614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation kinetics and mechanisms of moricizine hydrochloride in acidic medium.
    King SP; Sigvardson KW; Dudzinski J; Torosian G
    J Pharm Sci; 1992 Jun; 81(6):586-91. PubMed ID: 1522500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose and multiple-dose pharmacokinetics of etintidine in healthy volunteers.
    Huang SM; Marriott TB; Weintraub HS; Arnold JD; Boccagno J; Abels R; Harris W
    Eur J Clin Pharmacol; 1988; 34(1):101-4. PubMed ID: 2896125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of etintidine in rat, dog, and human.
    Wong FA; Lloyd JR; Graden DW
    Drug Metab Dispos; 1990; 18(6):949-53. PubMed ID: 1981542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The action of various doses of the new imidazole H2-receptor antagonist etintidine on intragastric acidity in man].
    Dammann HG; Rehner M; Dreyer M; Walter TA; Müller P; Simon B
    Arzneimittelforschung; 1986 Nov; 36(11):1699-701. PubMed ID: 2880596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (Imidazolylphenyl)formamidines. A structurally novel class of potent histamine H2 receptor antagonists.
    Donetti A; Cereda E; Bellora E; Gallazzi A; Bazzano C; Vanoni P; Del Soldato P; Micheletti R; Pagani F; Giachetti A
    J Med Chem; 1984 Mar; 27(3):380-6. PubMed ID: 6142117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural studies on H2-antagonists: crystal and molecular structure of N-cyano-N'-methyl-N"-(2-[(2-amino-5-thiazolyl)methylthio]ethyl) guanidine and N-cyano-3-[(2-guanidino-5-thiazolyl)methylthio]propionamidine.
    Ianelli S; Pelizzi G
    Farmaco; 1992 May; 47(5):607-21. PubMed ID: 1356342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of etintidine, a new histamine H2-receptor antagonist.
    Scott CK; Katz LB; Shriver DA
    Arch Int Pharmacodyn Ther; 1986 May; 281(1):5-21. PubMed ID: 2875695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical method for the quantification of famotidine, an H2-receptor blocker, in plasma and urine.
    Vincek WC; Constanzer ML; Hessey GA; Bayne WF
    J Chromatogr; 1985 Mar; 338(2):438-43. PubMed ID: 2860117
    [No Abstract]   [Full Text] [Related]  

  • 12. Stability of ricobendazole in aqueous solutions.
    Wu Z; Tucker IG; Razzak M; Medlicott NJ
    J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic evaluation of etintidine (BL-5641), a novel histamine H2-receptor antagonist, using reverse mutation tests in bacteria and forward mutation tests in V79 Chinese hamster cells.
    Ishida F; Kondo H; Fukushima M; Kamei T
    Mutat Res; 1987 Aug; 188(4):301-6. PubMed ID: 2886910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aqueous stability and solubility of CI-988, a novel "dipeptoid" cholecystokinin-B receptor antagonist.
    Kearney AS; Mehta SC; Radebaugh GW
    Pharm Res; 1992 Aug; 9(8):1092-5. PubMed ID: 1409383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of food or milk on the bioavailability of etintidine in healthy subjects.
    Huang SM; Marriott TB; Weintraub HS; Boccagno JA; Abels R
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):113-7. PubMed ID: 2900817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of S-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]glutathione and its derivatives as proposed precursors of S-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]cysteine, a compound found in human urine.
    Kinuta M; Ubuka T; Yao K; Yamada S; Yukihiro K; Tomozawa M
    Biochim Biophys Acta; 1993 Jun; 1157(2):192-8. PubMed ID: 8507655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New degradation product of spiradoline mesylate in aqueous solution: formation of an imidazolidine ring.
    Ogata M; Shimizu R; Abe H
    J Pharm Sci; 1993 Jan; 82(1):91-4. PubMed ID: 8429499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of imatinib mesylate degradation products obtained under stress conditions.
    Szczepek WJ; Kosmacińska B; Bielejewska A; Łuniewski W; Skarzyński M; Rozmarynowska D
    J Pharm Biomed Anal; 2007 Apr; 43(5):1682-91. PubMed ID: 17307328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of 2,2'-azobis (2-amidinopropane) dihydrochloride degradation and hydrolysis in aqueous solutions.
    Werber J; Wang YJ; Milligan M; Li X; Ji JA
    J Pharm Sci; 2011 Aug; 100(8):3307-3315. PubMed ID: 21560126
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.